Literature DB >> 23592851

Inappropriate dose of enteral antimicrobials promotes resistance.

L Silvestri, C Negri, N Taylor, D F Zandstra, H K F van Saene.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 23592851      PMCID: PMC3647897          DOI: 10.1128/JCM.00152-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  8 in total

1.  Use of international units when dosing colistin will help decrease confusion related to various formulations of the drug around the world.

Authors:  Matthew E Falagas; Sofia K Kasiakou
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

2.  Microbial gut overgrowth guarantees increased spontaneous mutation leading to polyclonality and antibiotic resistance in the critically ill.

Authors:  H K F van Saene; N Taylor; V Damjanovic; R E Sarginson
Journal:  Curr Drug Targets       Date:  2008-05       Impact factor: 3.465

3.  Emergence of OXA-48 and OXA-181 carbapenemases among Enterobacteriaceae in South Africa and evidence of in vivo selection of colistin resistance as a consequence of selective decontamination of the gastrointestinal tract.

Authors:  Adrian J Brink; Jennifer Coetzee; Craig Corcoran; Cornelis G Clay; Danusha Hari-Makkan; Rachael K Jacobson; Guy A Richards; Charles Feldman; Louise Nutt; Johan van Greune; J D Deetlefs; Karin Swart; Lesley Devenish; Laurent Poirel; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2012-11-14       Impact factor: 5.948

4.  Influence of faeces on the activity of antimicrobial agents used for decontamination of the alimentary canal.

Authors:  J J van Saene; H K van Saene; C P Stoutenbeek; C F Lerk
Journal:  Scand J Infect Dis       Date:  1985

5.  Enterobacteriaceae suppression by three different oral doses of polymyxin E in human volunteers.

Authors:  J J van Saene; H K van Saene; N J Tarko-Smit; G J Beukeveld
Journal:  Epidemiol Infect       Date:  1988-06       Impact factor: 2.451

6.  Colistin resistance in gram-negative bacteria during prophylactic topical colistin use in intensive care units.

Authors:  Evelien A N Oostdijk; Loek Smits; Anne Marie G A de Smet; Maurine A Leverstein-van Hall; Jozef Kesecioglu; Marc J M Bonten
Journal:  Intensive Care Med       Date:  2012-12-01       Impact factor: 17.440

Review 7.  Selective decontamination of the digestive tract: the mechanism of action is control of gut overgrowth.

Authors:  Luciano Silvestri; Miguel A de la Cal; Hendrick K F van Saene
Journal:  Intensive Care Med       Date:  2012-09-22       Impact factor: 17.440

8.  Decontamination of the digestive tract and oropharynx in ICU patients.

Authors:  A M G A de Smet; J A J W Kluytmans; B S Cooper; E M Mascini; R F J Benus; T S van der Werf; J G van der Hoeven; P Pickkers; D Bogaers-Hofman; N J M van der Meer; A T Bernards; E J Kuijper; J C A Joore; M A Leverstein-van Hall; A J G H Bindels; A R Jansz; R M J Wesselink; B M de Jongh; P J W Dennesen; G J van Asselt; L F te Velde; I H M E Frenay; K Kaasjager; F H Bosch; M van Iterson; S F T Thijsen; G H Kluge; W Pauw; J W de Vries; J A Kaan; J P Arends; L P H J Aarts; P D J Sturm; H I J Harinck; A Voss; E V Uijtendaal; H E M Blok; E S Thieme Groen; M E Pouw; C J Kalkman; M J M Bonten
Journal:  N Engl J Med       Date:  2009-01-01       Impact factor: 91.245

  8 in total
  2 in total

1.  Colistin, SDD and resistance: nihil novi sub sole.

Authors:  Luciano Silvestri; Nia Taylor; Hendrick K F van Saene; Jan Bakker
Journal:  Intensive Care Med       Date:  2014-05-27       Impact factor: 17.440

2.  Long-term use of selective digestive decontamination in an ICU highly endemic for bacterial resistance.

Authors:  Catalina Sánchez-Ramírez; Silvia Hípola-Escalada; Miriam Cabrera-Santana; María Adela Hernández-Viera; Liliana Caipe-Balcázar; Pedro Saavedra; Fernando Artiles-Campelo; Nayra Sangil-Monroy; Carlos Federico Lübbe-Vázquez; Sergio Ruiz-Santana
Journal:  Crit Care       Date:  2018-05-30       Impact factor: 9.097

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.